Navigation Links
UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
Date:4/3/2008

YOQNEAM, Israel and SAN RAMON, California, April 3 /PRNewswire/ -- Results of an independent multi-treatment clinical study of the UltraShape(R) Contour I, the first clinically proven non-invasive solution for fat reduction and body contouring using non-thermal selective focused ultrasound will be presented at the American Society for Laser Medicine and Surgery annual meeting on April 4, 2008 in Kissimmee, Florida. The presentation is entitled "Lipotripsy: Non-invasive Ultrasonic Selective Destruction of Adipocytes using UltraShape" will take place during the scientific session The Cutting Edge in Optical Diagnostics and Therapeutics of Tissues and Cells.

Hector Leal-Silva, M.D., a dermatologic surgeon based in Monterrey, Mexico, will present the results of the 36 patient clinical study using the UltraShape system on localized fat deposits in the abdomen, flanks, and thighs. The study showed definitive, measurable results in 100 percent of patients including an average of two-inch (5cm) reduction in circumference in the abdomen after a series of three treatments, one month apart. CT scans taken in a subset of study subjects showed objective quantifiable fat thickness reduction. Photographic assessment, weight and circumferential measures were evaluated before and after each treatment and one month after the last treatment. Visual contour improvement was seen in over 85% of patients as assessed by an independent panel of physicians. Ninety-four percent (94%) of patients were satisfied with the procedure. In addition, there were no adverse events reported.

"With the major shift in patient demand toward non-invasive, pain-free, no-downtime procedures UltraShape has become a core procedure offering in my aesthetic practice," said Leal. "My clinical study demonstrated measurable circumference reduction and visual improvement in body contour in all patients. Moreover, my patients are happy with a high percentage of them returning for treatment of othe
'/>"/>

SOURCE UltraShape Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
2. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
3. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
4. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
5. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
6. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
7. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
8. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
9. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
10. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
11. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
(Date:6/19/2013)... Dr. Davis Lee , CMIO for PIH Health ... 2013 AMDIS Award, a prestigious recognition saluting excellence and ... "On behalf of Allscripts, I,d like to congratulate Dr. ... efforts to improve patient care and population health," said ... Officer of Allscripts. "We are committed to our partnership ...
(Date:6/19/2013)... , June 19, 2013 The American Association ... from Maryland , announced today the filing ... Washington, D.C. , asking that the scheduled ... for durable medical equipment (DME) be stopped because of serious ... Health and Human Services (HHS) Secretary Kathleen Sebelius ...
Breaking Medicine Technology:Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5
... After Ozarelix Was Maintained For ... Up To Six Months, ... Thereafter, IRVINE, Calif., Sept. 5 Spectrum,Pharmaceuticals, Inc., (Nasdaq: SPPI ... Company,s drug candidate for the,treatment of benign prostatic hypertrophy (BPH), at the ...
... Hosts Key Investigator Meeting for European Participants in ... 3 AGENDA Trial Targeting Biomarker-Defined Population, ... (Nasdaq: GNTA ) announced that data from ... plus chemotherapy would be,presented at the opening session ...
Cached Medicine Technology:Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 3Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 4Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 5Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5
(Date:6/19/2013)... 19, 2013 PrettySkin4Less announces it is ... serums by top skin care manufacturer EMINENCE to ... of vitamins, minerals and active organic ingredients to promote ... many other beauty products offer. For this reason it’s ... , "I like products that do what they ...
(Date:6/19/2013)... Salt Lake City, UT (PRWEB) June 19, 2013 ... wellness companies : , In July 2013, Orriant ... optimize their participation rates, and maintain compliance with ... implemented allowing employees to receive wellness incentives if ... Orriant has announced they have been compliant with ...
(Date:6/19/2013)... As Januvia lawsuit ... in courts throughout the U.S., Bernstein Liebhard LLP notes ... held a meeting to discuss the safety of Januvia ... According to a June 12th report from Bloomberg.com, the ... Januvia and similar drugs, following a recent study that ...
(Date:6/19/2013)... is believed to be the largest follow-up record of ... a movement disorder that can cause crippling muscle ... success rates and lasting benefits. , Michele Tagliati, MD, ... Medical Center,s Department of Neurology, and Ron L. Alterman, ... Israel Deaconess Medical Center in Boston, published the study ...
(Date:6/19/2013)... study reveals significant disparities between minority and white ... treatment programs. Moreover, these disparities vary widely from ... that for most states there,s something amiss," says ... biostatistics. "There are strong racial and ethnic disparities ... abuse treatment programs successfully, and those disparities are ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... PharmaTech (Cayman) Inc.,(NYSE: WX ), a leading ... with operations in China and the,United States, today announced ... WuXi PharmaTech Board of Directors. , ... Dr. Ge Li, WuXi,s Chairman and Chief ...
... Receptors and Cell Signaling at UH and MethodistHOUSTON, Feb. ... of a $5.5 million grant to the University ... (ETF). As a result of the ETF grant, UH ... to carry out laboratory research and to create next-generation ...
... today for the event to take place November 21-22 ... 5 The Leukemia & Lymphoma Society (LLS) and ... officials, announcement today granting the two organizations permission to ... November 21-22, 2009. The event, Women,s Running ...
... W.Va., Feb. 5 ReBuilder Medical Technologies, Inc. (Pink ... treatments for diabetic peripheral neuropathy and ... increase in sales for the month of January. (Logo: ... appear to be recession proof and this monthly sales ...
... unemployment rate facing Americans with disabilities , WASHINGTON, Feb. ... the first time, release employment and unemployment data on ... information will assist the nation in understanding how changing ... it is widely believed that this group typically faces ...
... February 5, 2009 Narcotics have an irreversible effect ... illness, according to Dr. Stphane Potvin of the Universit ... Louis-H Lafontaine Hospital. , According to his research, ... suffer from drug addiction. The study has shown that ...
Cached Medicine News:Health News:WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board 2Health News:WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board 3Health News:Internationally Acclaimed Researcher Joins UH Faculty 2Health News:Internationally Acclaimed Researcher Joins UH Faculty 3Health News:Internationally Acclaimed Researcher Joins UH Faculty 4Health News:Internationally Acclaimed Researcher Joins UH Faculty 5Health News:Internationally Acclaimed Researcher Joins UH Faculty 6Health News:The Leukemia & Lymphoma Society and Women's Running Magazine Join Forces to Launch New All-Women Half Marathon in St. Petersburg 2Health News:ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09 2Health News:U.S. Labor Department to begin new monthly data series on people with disabilities from Current Population Survey on Feb. 6 2
... is an FDA approved rapid ... blood test used to aid ... infection. This CLIA waived test, ... antibodies to HIV-1, requires only ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
... Influenza A+B test allows for the ... A and type B antigens directly ... nasal aspirate specimens. The test is ... rapid differential diagnosis of acute influenza ...
Medicine Products: